Pangenomic Health Inc.
NARA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 70.43% | 70.27% | 82.57% | 75.38% | -120.39% |
| Total Depreciation and Amortization | -6.67% | 3.37% | 5.75% | 7.06% | 12.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.91% | -73.54% | -97.86% | -97.62% | 264.05% |
| Change in Net Operating Assets | -48.29% | 16.20% | 183.58% | 434.68% | 415.03% |
| Cash from Operations | 76.95% | 81.90% | 72.99% | 45.92% | 52.78% |
| Capital Expenditure | 100.00% | 100.00% | 100.00% | 51.06% | 77.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -227.82% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 100.00% | 94.06% | -322.09% |
| Total Debt Issued | 214.21% | -20.27% | 179.48% | 582.04% | -130.51% |
| Total Debt Repaid | 200.00% | 200.00% | 200.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -99.97% | -74.81% | 87.58% |
| Repurchase of Common Stock | -11,866.67% | 90.17% | 90.17% | 90.17% | 99.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 11.11% | -- | -- | -- |
| Cash from Financing | -76.38% | -65.86% | -64.64% | -8.67% | 33.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 206.84% | 101.09% | 101.62% | 94.22% | 99.27% |